Approved for Short-term management of cardiac decompensation due to depressed contractility (e.g., acute heart failure, cardiogenic shock, post-cardiac surgery). Selectively stimulates beta-1 adrenergic receptors in the heart, increasing myocardial contractility and cardiac output with relatively less effect on heart rate and peripheral vascular resistance… Side effects, costs, interactions,…
Loading full data from Know Your Drugs Institute…